Search results for "iontophoresi"

showing 10 items of 69 documents

Nitric oxide modulates striatal neuronal activity via soluble guanylyl cyclase: an in vivo microiontophoretic study in rats.

2003

It is now well established that nitric oxide (NO) acts as a neuromodulator in the central nervous system. To assess the role of NO in modulating striatal activity, single-unit recording was combined with iontophoresis to study presumed spiny projection neurons in urethane-anesthetized male rats. Striatal neurons recorded were essentially quiescent and were therefore activated to fire by the iontophoretic administration of glutamate, pulsed in cycles of 30 sec on and 40 sec off. In this study, iontophoresis of 3-morpholinosydnonimine hydrochloride (SIN 1), a nitric oxide donor, produced reproducible, current-dependent inhibition of glutamate-induced excitation in 12 of 15 striatal neurons, r…

MaleAction PotentialsReceptors Cytoplasmic and NuclearPharmacologyMedium spiny neuronNitric OxideNitric oxideCellular and Molecular Neurosciencechemistry.chemical_compoundSoluble Guanylyl CyclasePremovement neuronal activityAnimalsRats WistarCyclic guanosine monophosphateNeuronsbiologyIontophoresisGlutamate receptorIontophoresisCorpus StriatumRatsNitric oxide synthasenervous systemchemistryBiochemistrySolubilityGuanylate CyclaseMolsidominebiology.proteinSoluble guanylyl cyclaseSynapse (New York, N.Y.)
researchProduct

Iontophoresis for Therapeutic Drug Delivery and Non-invasive Sampling Applications

2017

Most research concerning iontophoresis has focused on topical and transdermal drug delivery and in non-invasive skin sampling applications. Iontophoresis has been established as a safe, versatile and efficient enhancement technique, and several iontophoretic devices have been marketed for topical (lidocaine) and systemic (fentanyl, sumatriptan) delivery and for non-invasive sampling (glucose). Nevertheless, the last decade has seen an increased interest into the potential use of iontophoresis to deliver drugs through the nail and through the sclera and cornea, the two main barriers to eye drug delivery. This chapter aims to summarize the main progress achieved in these areas.

IontophoresisLidocainebusiness.industryFentanyl03 medical and health sciencesSumatriptan0302 clinical medicineAnesthesiaDrug delivery030221 ophthalmology & optometryMedicinebusinessNon invasive sampling030217 neurology & neurosurgerymedicine.drugTransdermal
researchProduct

Effects of melatonin on spontaneous electrical activity of neurons in rat suprachiasmatic nuclei: an in vitro iontophoretic study.

1989

Circadian rhythms, endogenously generated in suprachiasmatic nuclei (SCN), seem to be under the direct influence of melatonin. Therefore, the effect of iontophoretically applied melatonin on electrical activity of SCN neurons was investigated in vitro. Usually, melatonin had an inhibitory effect. In the 3-h periods before (2.00-5.00 p.m.) or after (5.00-8.00 p.m.) the light-dark transition the percentage of SCN neurons sensitive to melatonin was very high (80% and 100%, respectively). However, efficacy of melatonin was low in the periods preceeding (20%) and following (33%) this 6-h time interval.

Malemedicine.medical_specialtyCentral nervous systemAction PotentialsBiologyIn Vitro TechniquesMelatoninInternal medicinemedicineAnimalsCircadian rhythmBiological PsychiatryMelatoninNeuronsIontophoresisSuprachiasmatic nucleusIontophoresisIn vitroCircadian RhythmRatsPsychiatry and Mental healthElectrophysiologyEndocrinologymedicine.anatomical_structureNeurologyHypothalamusSuprachiasmatic NucleusNeurology (clinical)medicine.drugJournal of neural transmission
researchProduct

Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features

2006

Abstract In transbuccal absorption a major limitation could be the low permeability of the mucosa which implies low drug bioavailability. The ability of naltrexone hydrochloride (NLX) to penetrate a resembling histologically human buccal mucosa was assessed and the occurrence of any histomorphological changes observed. We used reconstituted human oral (RHO) non-keratinised epithelium as mucosal section and a Transwell diffusion cells system as bicompartmental model. Buccal permeation was expressed in terms of drug flux ( J s ) and permeability coefficients ( K p ). Data were collected using both artificial and natural human saliva. The main finding was that RHO does not restrain NLX permeat…

Naltrexone HydrochlorideSalivaTissue FixationCell SurvivalNarcotic AntagonistsPharmaceutical SciencePharmacologySettore MED/08 - Anatomia PatologicaEpitheliumPermeabilityAbsorptionDiffusionExcipientsSettore MED/28 - Malattie OdontostomatologichemedicineHumansNaltrexone hydrochlorideNLXIontophoresiBuccal permeationTransbuccal absorptionParaffin EmbeddingIontophoresisChemistryNarcotic antagonistMouth MucosaAdministration BuccalGeneral MedicineBuccal administrationIontophoresisPermeationReconstituted human oral epithelium (RHO)Electric StimulationNaltrexoneEpitheliummedicine.anatomical_structurePenetration enhancersSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoData Interpretation StatisticalBiophysicsBiotechnology
researchProduct

Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140—A Multitarget Compound for Alzheimer’s Disease

2019

ARN14140 is a galantamine-memantine conjugate that acts upon both cholinergic and glutamatergic pathways for better management of Alzheimer's disease. Poor oral bioavailability and pharmacokinetics meant that earlier preclinical in vivo studies employed intracerebroventricular injection to administer ARN14140 directly to the brain. The aim of the present study was to evaluate the feasibility of using constant current transdermal iontophoresis for the noninvasive systemic delivery of ARN14140 and to quantify the amounts present in the blood and the brain. Preliminary experiments in vitro were performed using porcine skin and validated with human skin. Cumulative ARN14140 permeation across th…

MaleSwineSkin Absorptionbrain deliveryBiological AvailabilityPharmaceutical ScienceHuman skin02 engineering and technologyPharmacologyAdministration Cutaneous030226 pharmacology & pharmacyPermeability03 medical and health sciences0302 clinical medicineDrug StabilityPharmacokineticsIn vivoDrug DiscoveryARN14140AnimalsBrain/metabolismHumansSkin/metabolismMedicineTissue DistributionRats WistarNootropic Agents/administration & dosage/pharmacokineticsTransdermalddc:615galantamine-memantine conjugateAlzheimer Disease/drug therapyIontophoresisbusiness.industryGalantamine/administration & dosage/pharmacokineticsiontophoresiIontophoresisMemantine/administration & dosage/pharmacokinetics021001 nanoscience & nanotechnologyIn vitroRatsBioavailabilityHeterocyclic Compounds 4 or More Rings/administration & dosage/pharmacologytransdermalFeasibility StudiesMolecular MedicineCholinergic0210 nano-technologybusinessMolecular Pharmaceutics
researchProduct

Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's dise…

2018

[EN] Effective treatment of Parkinson's disease (PD) involves administration of therapeutic agents with complementary mechanisms of action in order to replenish, sustain or substitute endogenous dopamine. The objective of this study was to investigate anodal co-iontophoresis of pramipexole (PRAM; dopamine agonist) and rasagiline (RAS; MAO-B inhibitor) in vitro and in vivo. Passive permeation of PRAM and RAS (20 mM each) across porcine skin after 6 h was 15.7 +/- 1.9 and 16.0 +/- 2.9 mu g/cm(2), respectively. Co-iontophoresis at 0.15, 0.3 and 0.5 mA/cm(2) resulted in statistically significant increases in delivery of PRAM and RAS; at 0.5 mA/cm(2), cumulative permeation of PRAM and RAS was 61…

MaleParkinson's diseaseSwineChemistry PharmaceuticalSkin AbsorptionPharmaceutical SciencePharmacologyAdministration Cutaneous030226 pharmacology & pharmacyDopamine agonistPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePramipexolePharmacokineticsIn vivomedicineAnimalsHumansBenzothiazolesMAO-B inhibitorRats WistarTransdermalSkinRasagilinePramipexoleIontophoresisDopamine agonistPatient complianceParkinson DiseaseGeneral MedicineIontophoresismedicine.diseaseRatschemistryIndansPolypharmacyElectroosmosisTransdermal030217 neurology & neurosurgeryBiotechnologymedicine.drugEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Regulation of noradrenergic coerulean neuronal firing mediated by 5-HT2 receptors: involvement of the prepositus hypoglossal nucleus.

1991

Abstract Previous studies have indicated a 5-HT2-mediated inhibitory influence on unit activity in the locus coeruleus. In the present work, attempts were made to determine which area(s) of the brain is (are) involved in this effect: (1) Microiontophoretic application of serotoninergic compounds (quipazine, ketanserin, RU 24969 (Roussel Uclaf), 8-hydroxy-2(di-n-propylamino) tetralin (8-OH-DPAT), metergoline, serotonin) in the locus coeruleus, did not alter the coerulean discharge. Local microinjection of quipazine or ketanserin in the area of the locus coeruleus, as well as in one of its major afferents, the prepositus hypoglossi, had no effect on the unit activity in the locus coeruleus. 1…

Maleendocrine systemMetergolinemedicine.medical_specialtyHypoglossal NerveSerotoninKetanserinHypoglossal nucleusMicroinjectionsSerotonergicLigandsCellular and Molecular Neurosciencechemistry.chemical_compoundNorepinephrineNorepinephrineInternal medicinemedicineAnimalsheterocyclic compoundsNeurons Afferent5-HT receptorPharmacologyNeuronsChemistrymusculoskeletal neural and ocular physiologyQuipazineRats Inbred StrainsIontophoresisRatsEndocrinologynervous systemReceptors SerotoninLocus coeruleusRaphe NucleiLocus CoeruleusNeurosciencemedicine.drugNeuropharmacology
researchProduct

Current Progress in Particle-Based Systems for Transdermal Vaccine Delivery

2020

Transcutaneous immunization (TCI) via needle-free and non-invasive drug delivery systems is a promising approach for overcoming the current limitations of conventional parenteral vaccination methods. The targeted access to professional antigen-presenting cell (APC) populations within the skin, such as Langerhans cells (LCs), various dermal dendritic cells (dDCs), macrophages, and others makes the skin an ideal vaccination site to specifically shape immune responses as required. The stratum corneum (SC) of the skin is the main penetration barrier that needs to be overcome by the vaccine components in a coordinated way to achieve optimal access to dermal APC populations that induce priming of…

lcsh:Immunologic diseases. AllergyOvalbuminMini ReviewT-Lymphocytesparticulate systemsImmunologyAntigen-Presenting CellsAdministration CutaneousSonicationDrug Delivery SystemsImmune systemtranscutaneous immunizationAdjuvants ImmunologicAntigenvaccine particlesStratum corneumHumansImmunology and AllergyMedicineVaccines Virus-Like ParticleParticle SizeTransdermalIontophoresisintegumentary systembusiness.industryElectroporationVaccinationDermisPeptide Fragmentsneedle-free vaccinationVaccinationElectroporationmedicine.anatomical_structureLangerhans CellsLiposomesImmunologyDrug deliverydrug deliveryInjections JetnanoparticlesLymph NodesPharmaceutical Vehiclesbusinesslcsh:RC581-607Frontiers in Immunology
researchProduct

Iontophoresis: electrorepulsion and electroosmosis.

2000

Over the last 10-15 years, the electrical enhancement of drug delivery across the skin has undergone intense investigation. During this period, considerable amounts of experimental data have been generated, and the successful enhancement of a diverse array of molecules has been achieved. Indeed, the commercial exploitation of the method can be envisaged within the next few years. Despite this progress, however, the mechanistic understanding of iontophoresis remains a challenging scientific question that is yet to be fully resolved. The routes of permeation under the influence of an applied electrical potential, and the molecular interactions of the transporting drug with these pathways, hav…

ddc:615Molecular interactionsOsmosisIontophoresisChemistryPharmaceutical ScienceNanotechnologyIontophoresisAdministration CutaneousDrug Delivery SystemsPharmaceutical technologyElectricitySkin Physiological PhenomenaDrug deliveryDrug Delivery Systems/methodsJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Polymeric nanospheres as strategy to increase the amount of triclosan retained in the skin: passive diffusion vs. iontophoresis

2012

The aim of this study was to evaluate the passive and iontophoretic permeation of triclosan in human skin using a triclosan solution and triclosan-loaded cationic nanospheres in order to determine which of the two strategies is more effective in allowing the deposition of triclosan within the skin. Triclosan-loaded nanospheres were prepared by the emulsification-solvent displacement technique using aminoalkyl methacrylate (Eudragit® RL 100) as polymer matrix. Nanospheres of 261.0 ± 15.1 nm with a positive surface charge (Ψz = 26.0 ± 3.2 mV) were obtained. Drug loading was 62.0 ± 1.7%. Results demonstrated that the amount of triclosan retained within the skin was significantly greater (8.5-f…

Materials sciencePharmaceutical ScienceBioengineeringHuman skinMethacrylateDiffusionchemistry.chemical_compoundColloid and Surface ChemistryParticle SizePhysical and Theoretical ChemistrySolubilityChromatography High Pressure LiquidSkinChromatographyIontophoresisOrganic ChemistryCationic polymerizationIontophoresisPermeationControlled releaseTriclosanTriclosanSolubilitychemistryMicroscopy Electron ScanningNanospheresJournal of Microencapsulation
researchProduct